132 related articles for article (PubMed ID: 36458571)
1. RFWD3 acts as a tumor promotor in the development and progression of bladder cancer.
Jiang P; Xu Z; Wu S; Sun J; Tian J; Chen X
Histol Histopathol; 2023 Aug; 38(8):917-928. PubMed ID: 36458571
[TBL] [Abstract][Full Text] [Related]
2. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of RFWD3 inhibits cancer cells proliferation and migration in gastric carcinoma.
Jia J; Yang Y; Yan T; Chen T; Lu G
Gen Physiol Biophys; 2020 Jul; 39(4):363-371. PubMed ID: 32902405
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of ZNF280A inhibits cell proliferation and promotes cell apoptosis of bladder cancer.
He L; Wang X; Chen P; Du C; Li J
Histol Histopathol; 2024 Mar; 39(3):367-379. PubMed ID: 37345848
[TBL] [Abstract][Full Text] [Related]
5. Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer.
Zhang Y; Zhao X; Zhou Y; Wang M; Zhou G
Front Med; 2020 Jun; 14(3):318-326. PubMed ID: 31571161
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
[TBL] [Abstract][Full Text] [Related]
8. RFWD3 Participates in the Occurrence and Development of Colorectal Cancer
Xu F; Xiao Z; Fan L; Ruan G; Cheng Y; Tian Y; Chen M; Chen D; Wei Y
Front Cell Dev Biol; 2021; 9():675356. PubMed ID: 34712656
[No Abstract] [Full Text] [Related]
9. HER2 Affects the Biological Behaviours of Bladder Cancer Cells and is Closely Associated with the Progression and Prognosis of Bladder Cancer.
Li Q; Su X; Qing L; Xu W; Yang Y; You C; Wang J; Dong Z
Arch Esp Urol; 2024 Jan; 77(1):79-91. PubMed ID: 38374017
[TBL] [Abstract][Full Text] [Related]
10. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
[TBL] [Abstract][Full Text] [Related]
12. C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients.
Zhu X; Tong H; Gao S; Yin H; Zhu G; Li X; He W; Gou X
Biomed Res Int; 2020; 2020():7139721. PubMed ID: 33123583
[TBL] [Abstract][Full Text] [Related]
13. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
Yang J; Fan L; Liao X; Cui G; Hu H
Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
[TBL] [Abstract][Full Text] [Related]
14. MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression.
Shang A; Yang M; Shen F; Wang J; Wei J; Wang W; Lu W; Wang C; Wang C
Cell Physiol Biochem; 2017; 41(3):1179-1188. PubMed ID: 28268231
[TBL] [Abstract][Full Text] [Related]
15. MiR-133b regulates the proliferation, colony formation, and invasion of bladder cancer cells via inhibiting SOX4.
Zhong M; Jiang F; Song L; Nie M; Lan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):407-415. PubMed ID: 35545336
[TBL] [Abstract][Full Text] [Related]
16. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T
Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492
[TBL] [Abstract][Full Text] [Related]
17. Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
Bao Y; Liu X; Liu Y; Wang S; Wu B
Surg Oncol; 2019 Sep; 30():63-71. PubMed ID: 31500788
[TBL] [Abstract][Full Text] [Related]
18. ppGalNAc T1 as a potential novel marker for human bladder cancer.
Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP
Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233
[TBL] [Abstract][Full Text] [Related]
19. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W
Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733
[TBL] [Abstract][Full Text] [Related]
20. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
